Literature DB >> 6997974

Allergic perennial and non-allergic, vasomotor rhinitis treated with budesonide nasal spray.

V H Balle, U Pedersen, B Engby.   

Abstract

A recently synthetized, highly active, non-halogenated steroid, budesonide, in the form of a nasal spray was tested on 21 patients with an allergy demonstrated by means of cutaneous or RAST tests and 15 patients without allergy; these patients were further divided into two groups, 22 with nasal eosinophillia and 14 patients without. There was a significant effect on both patients with vasomotor as well as allergic rhinitis, and in patients with nasal eosinophilia, while this was not the case in the group without eosinophilia. Nasal eosinophilia must be considered an inexpensive and important diagnositic tool for the clarification of perennial rhinitis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6997974

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  4 in total

Review 1.  Progress in the drug management of allergic rhinitis.

Authors:  N Mygind
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

2.  Acute dose-response studies in bronchial asthma with a new corticosteroid, budesonide.

Authors:  R Ellul-Micallef; S A Johansson
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

Review 3.  Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis.

Authors:  S P Clissold; R C Heel
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

4.  Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated.

Authors:  Harsha H Kariyawasam; Glenis K Scadding
Journal:  J Asthma Allergy       Date:  2010-06-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.